Медицинский вестник Юга России

Расширенный поиск


Полный текст:


В статье представлен литературный обзор, посвященный некоторым историческим аспектам медикаментозного лечения ожирения, и описаны перспективы развития новых препаратов.

Об авторах

Н. И. Волкова
Ростовский государственный медицинский университет, Кафедра внутренних болезней с основами общей физиотерапии № 3

М. И. Поркшеян
Ростовский государственный медицинский университет, Кафедра внутренних болезней с основами общей физиотерапии № 3

А. Н. Гюльмагомедова
Ростовский государственный медицинский университет, Кафедра внутренних болезней с основами общей физиотерапии № 3

Список литературы

1. Putnam J.J. Cases of myxoedema and acromegalia treated with benefi t by sheep’s thyroids: recent observations respecting the pathology of the cachexias following disease of the thyroid; clinical relationships of Grave’s disease and acromegalia // Am J Med Sci. 1983.106: 125–148.

2. DuBois E.F. Basal metabolism in health and disease. Lea and Febiger, Philadelphia, 1924.

3. Bray G.A., Melvin K.E.W., Chopra I.J. Eff ect of triiodothyronine on some metabolic responses of obese patients //Am J Clin Nutr. 1973. 26: 715–721.

4. Ravussin E., Lillioja S., Anderson T.E., Christin L., Bogardus C. Determinants of 24-hour energy expenditure in man: methods and results using a respiratory chamber //J Clin Invest. 1986.78:1568–1578.

5. Ehrlich P, Hata SюDie experimentelle Chemotherapie der Spirillosen. Julius Springer, Berlin, 1910.

6. Simkins S. Dinitrophenol and desiccated thyroid in the treatment of obesity: a comprehensive clinical and laboratory study // JAMA. 1937. 108: 2110–2193.

7. Nathanson M.H. Th e central action of beta-aminopropylbenzene (Benzedrine) //JAMA. 1937. 108: 528–531.

8. Davidoff E., Reifenstein E.C. Jr. Th e stimulating action of benzedrine sulfate: a comparative study of the responses of normal persons and of depressed patients // JAMA. 1937.108: 1770–1776.

9. Ulrich H. Narcolepsy and its treatment with benzedrine sulfate // N EngI J Med. 1937.217(18): 696–701.

10. Lesses M.F., Myerson A. Human autonomic pharmacology XVI: benzedrine sulfate as an aid in the treatment of obesity //N Engl J Med. 1938.218: 119–124.

11. Leibowitz S.F., Rossakis C. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol //Eur Pharm. 1978.53: 69–81.

12. Weintraub M. Long-term weight control, the National Heart, Lung and Blood Institute funded multimodal intervention study //Clin Pharmacol Th er. 1992.51(5): 581–585.

13. FDA letter to manufacturers of drug products containing Phenylpropanolamine (PPA) dated 11/03/2000.

14. Derosa G., Maffi oli P. Anti-obesity drugs: a review about their eff ects and their safety // Expert Opin. Drug Saf. 2012. 11(3): 459–471.

15. Luque C.A., Rey A.J. Th e discovery and status of sibutramine as an anti-obesity drug //European Journal of Pharmacology. 2002. 440:119–128.

16. James W.P.T., Caterson I.D., Coutinho W et al. for the SCOUT Investigators. Eff ect of sibutramine on cardiovascular outcomes in overweight and obese subjects //N Engl J Med. 2010. 363:905–17.

17. European Medicines Agency recommends suspension of marketing authorisations for sibutramine. Press release of the European Medicines Agency, London, January 21, 2010 [Electronic resource] // EMA[Offi cial website]. Feb. 2015.http://дата обращения: 24.02.2015).

18. Kirkham T.C. Cannabinoids and appetite: food craving and food pleasure //Int Rev Psychiatry. 2009. 21(2): 163–71.

19. Rang & Dales Pharmacology. Obesity. Elsevier. 2015.

20. Plieth J. Obesity: what next aft er the CB1 antagonists’ failure // Scrip 2008.3411/3412: 44–47.

21. Rodgers R.J., Tschop M.H., Wilding J.P.H. Anti-obesity drugs: past, present and future //Dis Model Mech. 2012. 5(5): 621–626.

22. Obesity drugs approved [Electronic resource] // FDA [Offi cial website]. Feb.дата обращения: 24.02.2015).

23. Под редакцией Дедова И.И.(Волкова Н.И.)Национальные клинические рекомендации по лечению морбидного ожирения у взрослых. 2011.

Для цитирования:

Волкова Н.И., Поркшеян М.И., Гюльмагомедова А.Н. ЛЕЧЕНИЕ ОЖИРЕНИЯ: ИСТОРИЯ ВЗЛЕТОВ И ПАДЕНИЙ. Медицинский вестник Юга России. 2015;(1):21-26.

For citation:

Volkova N.I., Porksheyan M.I., Gyulmagomedova A.N. TREATMENT FOR OBESITY: THE HISTORY OF FLIGHTS&FALLS. Medical Herald of the South of Russia. 2015;(1):21-26. (In Russ.)

Просмотров: 120

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)